𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease

✍ Scribed by Greenbaum, Lior; Israeli-Korn, Simon D.; Cohen, Oren S.; Elincx-Benizri, Sandra; Yahalom, Gilad; Kozlova, Evgenia; Strauss, Hanna; Molshatzki, Noa; Inzelberg, Rivka; Spiegelmann, Roberto; Israel, Zvi; Hassin-Baer, Sharon

Book ID
121324112
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
204 KB
Volume
19
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The G2019S LRRK2 mutation in Brazilian p
The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins
✍ Renato P. Munhoz; Yosuke Wakutani; Connie Marras; Helio A. Teive; Salmo Raskin; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

## Abstract Mutations in the Leucine‐Rich Repeat Kinase 2 gene (__LRRK2__) are mainly responsible for idiopathic Parkinson's disease (PD) with either a dominant pattern of transmission or a sporadic occurrence due to the reduced penetrance. A majority of __LRRK2__ kindreds demonstrate an extremely

Frequency and phenotypes of LRRK2 G2019S
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease
✍ Roberta Marongiu; Daniele Ghezzi; Tamara Ialongo; Francesco Soleti; Antonio Elia πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 74 KB

To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parkinson's disease (PD; 822 sporadic and 250 familial): 20 patients (1.9%) carried the G2019S mutation, 11 patients (1.3%) were sporadic, and 9 (4.3%) had a positive family history. Considering only proba